(Q35953330)

English

Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide (English)

1 reference

Europe PubMed Central

11 August 2017

Jan Willem Cohen Tervaert

2

object named as

Jan Willem Cohen Tervaert

1 reference

Europe PubMed Central

11 August 2017

author name string

Patricia M Stassen

1

1 reference

Europe PubMed Central

11 August 2017

Coen A Stegeman

3

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

19 December 2006

1 reference

Europe PubMed Central

11 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

11 August 2017

66

1 reference

Europe PubMed Central

11 August 2017

6

1 reference

Europe PubMed Central

11 August 2017

798-802

1 reference

Europe PubMed Central

11 August 2017

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Mechanisms of action of mycophenolate mofetil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

2 October 2017

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

11 July 2018

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954648

24 September 2018

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of Wegener's granulomatosis treated with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/17179175

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2006.060301

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35953330&oldid=1625632070"